Mesenchymal Stem Cell-derived Exosomes for the Treatment of Bronchiectatic Nontuberculous Mycobacterial Pulmonary Disease
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Nontuberculous mycobacterial pulmonary disease (NTM-PD) is a chronic and challenging infectious condition with rising global prevalence, and its bronchiectatic subtype is particularly difficult to treat with conventional regimens due to frequent adverse effects, thus necessitating novel therapeutic approaches. This report presents a 42-year-old female patient diagnosed with bronchiectatic NTM-PD, characterized by persistent cough, sputum production, and hemoptysis, which was confirmed through radiological findings and microbiological testing. Following intolerance to conventional antimicrobial therapy, the patient was treated exclusively with nebulized inhalation of human umbilical cord mesenchymal stem cell-derived exosomes (HucMSC-Exos). This intervention led to significant alleviation of respiratory symptoms, stabilization of pulmonary function, and marked improvement in immunological parameters. In conclusion, nebulized HucMSC-Exos therapy demonstrated successful outcomes in this case, improving clinical symptoms, pulmonary function, and immune status, which suggests its potential as a viable and innovative therapeutic strategy for managing this complex condition and warrants further clinical investigation.
Fields of Study & Subjects
Mycobacterium research and diagnosis
Extracellular vesicles in disease
Tuberculosis Research and Epidemiology
Publication details
- Journal / source
- International Journal of Mycobacteriology
- Volume
- 15
- Issue
- 1
- Pages
- 64–67
- Publication date
- 1 January 2026
- Language
- EN